New Cleveland Clinic research demonstrates the feasibility and validity of restoring native gut functions and nutritional autonomy in many gut failure patients using autologous gut reconstruction, without the need for gut transplantation.
Immunobiology of beta cell failure, genetic diabetes and islet cell therapy are among focal points of our “3rd Annual Beta Cell Symposium” CME course Nov. 9-10.
Meet Sammy: An energetic 8-year-old who received the first multivisceral transplant in a pediatric patient with Alagille syndrome, a rare genetic disorder that can lead to liver failure.
Cleveland Clinic is poised to launch the first U.S. study in which human liver transplant patients receive donor livers preserved using normothermic ex vivo perfusion.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Visceral transplantation and other innovative surgical procedures used to restore gut physiology and nutritional autonomy in patients with post-bariatric gut failure
This novel longitudinal initiative for adolescents discharged from a psychiatric inpatient unit improved their socialization and self-expression, and built a sense of community.
Learn how Cleveland Clinic’s intestinal rehabilitation program—one of the world’s largest and most comprehensive — treats intestinal failure patients using a multidisciplinary approach that achieves outstanding outcomes.
Before this 4-year-old boy got a four-organ transplant (intestine, duodenum, liver and pancreas), no one with Martinez-Frias syndrome survived past toddlerhood. Now 5, the boy is cured of his diabetes, off TPN and thriving. Lead transplant surgeon, Kareem Abu-Elmagd, MD, is gratified.